ARCH Venture Fund IX, L.P.'s Form 4 filing
Sana Biotechnology, Inc.SANA · filed Feb 12, 2024
- Accession no.
- 0001062993-24-002840
- Filed
- Feb 12, 2024, 5:43 PM ET
- Trade date
- Feb 8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $10.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| ARCH Venture Fund IX, L.P.CIK 0001666306 | 10% Owner |
| ARCH Venture Fund IX Overage, L.P.CIK 0001666307 | 10% Owner |
| ARCH Venture Partners IX Overage, L.P.CIK 0001723172 | 10% Owner |
| ARCH Venture Partners IX, L.P.CIK 0001723173 | 10% Owner |
| ARCH Venture Partners IX, LLCCIK 0001723174 | 10% Owner |
| ARCH Venture Fund X, L.P.CIK 0001757011 | 10% Owner |
| ARCH Venture Fund X Overage, L.P.CIK 0001757017 | 10% Owner |
| ARCH Venture Partners X Overage, L.P.CIK 0001768905 | 10% Owner |
| ARCH Venture Partners X, LLCCIK 0001769012 | 10% Owner |
| ARCH Venture Partners X, L.P.CIK 0001782583 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +363,637 | $5.50 | +$2,000,003.5 | 10,667,387 | Indirect | Duplicate filing |
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +727,272 | $5.50 | +$3,999,996 | 12,446,022 | Indirect | Duplicate filing |
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +727,272 | $5.50 | +$3,999,996 | 12,446,022 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 is one of two reports relating to the same transaction being filed jointly by ARCH IX, AVP IX LP, ARCH IX Overage, AVP IX Overage LP, AVP IX LLC, ARCH X, AVP X LP, ARCH X Overage, AVP X Overage LP, AVP X LLC, Keith Crandell, Clinton Bybee, Kristina Burow and Steven Gillis (collectively, the "Reporting Persons"). Robert Nelsen has direct ownership of Common Stock and is filing his own Form 4 separately.